{"id":"https://openalex.org/W2329465698","doi":"https://doi.org/10.2174/1874473708666150107120522","title":"A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects","display_name":"A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-09","ids":{"openalex":"https://openalex.org/W2329465698","doi":"https://doi.org/10.2174/1874473708666150107120522","mag":"2329465698","pmid":"https://pubmed.ncbi.nlm.nih.gov/25563445"},"language":"en","primary_location":{"id":"doi:10.2174/1874473708666150107120522","doi":"https://doi.org/10.2174/1874473708666150107120522","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1874473708666150107120522","pdf_url":null,"source":{"id":"https://openalex.org/S129558293","display_name":"Current Drug Abuse Reviews","issn_l":"1874-4737","issn":["1874-4737","1874-4745"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Abuse Reviews","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2329465698"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034075301","display_name":"Mitchell B. Liester","orcid":"https://orcid.org/0000-0003-4469-5185","observed_orcids":["https://orcid.org/0000-0003-4469-5185"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mitchell Liester","raw_affiliation_strings":["P.O. Box 302, 153 N. Washington Street, Suite 103, Monument, CO 80132, USA. liester@aol.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"P.O. Box 302, 153 N. Washington Street, Suite 103, Monument, CO 80132, USA. liester@aol.com","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5034075301"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.5175,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.93372122,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"7","issue":"3","first_page":"146","last_page":"156"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lysergic-acid-diethylamide","display_name":"lysergic acid diethylamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lsd","display_name":"LSD","score":0.9440000057220459},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.9390000104904175},{"id":"https://openalex.org/keywords/psychedelics","display_name":"psychedelics","score":0.8169999718666077},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.6240000128746033},{"id":"https://openalex.org/keywords/neurotransmitter-receptors","display_name":"neurotransmitter receptors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/gene-expression","display_name":"gene expression","score":0.9509999752044678},{"id":"https://openalex.org/keywords/counterculture","display_name":"counterculture","score":0.9150000214576721},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C2779871769","wikidata":"https://www.wikidata.org/wiki/Q23118","display_name":"Lysergic acid diethylamide","level":4,"score":0.9670723676681519},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.6478338837623596},{"id":"https://openalex.org/C2778889179","wikidata":"https://www.wikidata.org/wiki/Q415837","display_name":"Lysergic acid","level":2,"score":0.6271706223487854},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.5473405122756958},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.48954471945762634},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3273049592971802},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32726651430130005},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1852720081806183},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1015656590461731},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10018372535705566},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007880","descriptor_name":"Legislation, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008238","descriptor_name":"Lysergic Acid Diethylamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008238","descriptor_name":"Lysergic Acid Diethylamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008238","descriptor_name":"Lysergic Acid Diethylamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017981","descriptor_name":"Receptors, Neurotransmitter","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/1874473708666150107120522","doi":"https://doi.org/10.2174/1874473708666150107120522","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1874473708666150107120522","pdf_url":null,"source":{"id":"https://openalex.org/S129558293","display_name":"Current Drug Abuse Reviews","issn_l":"1874-4737","issn":["1874-4737","1874-4745"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Abuse Reviews","raw_type":"journal-article"},{"id":"pmid:25563445","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25563445","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug abuse reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W122113993","https://openalex.org/W156478726","https://openalex.org/W592732404","https://openalex.org/W648645029","https://openalex.org/W1582590726","https://openalex.org/W1595981698","https://openalex.org/W1940682915","https://openalex.org/W1970515876","https://openalex.org/W1973613743","https://openalex.org/W1975552694","https://openalex.org/W1976604434","https://openalex.org/W1980453588","https://openalex.org/W1983759112","https://openalex.org/W1984420194","https://openalex.org/W1985178027","https://openalex.org/W1988279571","https://openalex.org/W1998674360","https://openalex.org/W1999159677","https://openalex.org/W2002948808","https://openalex.org/W2005509461","https://openalex.org/W2024942419","https://openalex.org/W2026484120","https://openalex.org/W2041635830","https://openalex.org/W2050865511","https://openalex.org/W2053764826","https://openalex.org/W2063173231","https://openalex.org/W2068751924","https://openalex.org/W2075352853","https://openalex.org/W2075726441","https://openalex.org/W2079106221","https://openalex.org/W2088785539","https://openalex.org/W2089436854","https://openalex.org/W2093323137","https://openalex.org/W2093970972","https://openalex.org/W2095483365","https://openalex.org/W2104492171","https://openalex.org/W2110701839","https://openalex.org/W2111920357","https://openalex.org/W2122877802","https://openalex.org/W2128362026","https://openalex.org/W2129374552","https://openalex.org/W2129576675","https://openalex.org/W2150280237","https://openalex.org/W2153960249","https://openalex.org/W2155130148","https://openalex.org/W2186783883","https://openalex.org/W2312475727","https://openalex.org/W2409285196","https://openalex.org/W2411929905","https://openalex.org/W2417923099","https://openalex.org/W2418441138","https://openalex.org/W2419156332","https://openalex.org/W2422079377","https://openalex.org/W2473123625","https://openalex.org/W3105904203"],"related_works":["https://openalex.org/W3092650153","https://openalex.org/W2790421624","https://openalex.org/W2308102728","https://openalex.org/W2145095988","https://openalex.org/W7220197004","https://openalex.org/W2044398489","https://openalex.org/W3120466448","https://openalex.org/W2475677564","https://openalex.org/W2788130744"],"abstract_inverted_index":{"Lysergic":[0],"acid":[1],"diethylamide":[2],"(LSD)":[3],"is":[4,129,142],"a":[5,22,74,95,123,138],"semisynthetic":[6],"compound":[7],"with":[8,56,82,97],"strong":[9],"psychoactive":[10],"properties.":[11],"Chemically":[12],"related":[13],"to":[14,20,29,70,91],"serotonin,":[15],"LSD":[16,26,51],"was":[17,27],"initially":[18],"hypothesized":[19],"produce":[21],"psychosislike":[23],"state.":[24],"Later,":[25],"reported":[28],"have":[30],"benefits":[31,99],"in":[32,47,100],"the":[33,48,83,87,101,126],"treatment":[34,102,139],"of":[35,43,50,86,103,116,125],"addictions.":[36,104],"However,":[37],"widespread":[38,80],"indiscriminate":[39],"use":[40,72],"and":[41,89,112],"reports":[42],"adverse":[44],"affects":[45],"resulted":[46],"classification":[49],"as":[52,73,94,137],"an":[53],"illicit":[54],"drug":[55],"no":[57],"accepted":[58],"medical":[59],"use.":[60],"This":[61],"article":[62],"reviews":[63],"LSD's":[64,105,135],"storied":[65],"history":[66],"from":[67],"its":[68,71,79,92],"discovery,":[69],"research":[75,133],"tool,":[76],"followed":[77],"by":[78],"association":[81],"counterculture":[84],"movement":[85],"1960s,":[88],"finally":[90],"rebirth":[93],"medicine":[96],"potential":[98,136],"pharmacology,":[106],"phenomenology,":[107],"effects":[108,113],"at":[109],"neurotransmitter":[110],"receptors,":[111],"on":[114],"patterns":[115],"gene":[117],"expression":[118],"are":[119],"reviewed.":[120],"Based":[121],"upon":[122],"review":[124],"literature,":[127],"it":[128],"concluded":[130],"that":[131],"further":[132],"into":[134],"for":[140],"addictions":[141],"warranted.":[143]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2329465698","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
